Cannabinoids for drug-resistant seizures in a critically ill patient-Case report and literature review

被引:0
作者
Capra, Stefania [1 ]
Narayan, Sujita W. [2 ]
Parratt, Kaitlyn [3 ]
Patanwala, Asad E. [1 ,2 ]
机构
[1] Royal Prince Alfred Hosp, Dept Pharm, Camperdown, NSW, Australia
[2] Univ Sydney, Sch Pharm, Fac Med & Hlth, Sydney, NSW, Australia
[3] Royal Prince Alfred Hosp, Dept Neurol, Camperdown, NSW, Australia
关键词
cannabidiol; cannabis; drug-resistant; epilepsy; neurology; seizures; EPILEPSY; CANNABIDIOL; MARIJUANA; COMPLEMENTARY;
D O I
10.1111/jcpt.13082
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
What is known and objective Drug-resistant seizures are life-threatening and contribute to sustained hospitalization. We present the case of a critically ill 28-year-old male with Lennox-Gastaut syndrome who had approximately 30 seizures/day in the intensive care unit. Case description Patient required mechanical ventilation and pharmacologically induced thiopentone coma. He was commenced on cannabidiol and subsequently extubated. He remained seizure-free thereafter on a combination of cannabidiol and anti-epileptic medication that predated his critical illness. What is new and Conclusion Our case report provides a unique perspective on the role of cannabidiol in achieving remission from drug-resistant seizures in critically ill patients.
引用
收藏
页码:570 / 572
页数:3
相关论文
共 26 条
[1]   Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol [J].
Boggs, Douglas L. ;
Nguyen, Jacques D. ;
Morgenson, Daralyn ;
Taffe, Michael A. ;
Ranganathan, Mohini .
NEUROPSYCHOPHARMACOLOGY, 2018, 43 (01) :142-154
[2]   Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses [J].
Bruce, Douglas ;
Brady, John P. ;
Foster, Elissa ;
Shattell, Mona .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2018, 24 (02) :146-153
[3]  
Crowell Tara L, 2017, J Allied Health, V46, P232
[4]   Patients with refractory seizures [J].
Devinsky, O .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (20) :1565-1570
[5]   Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome [J].
Devinsky, Orrin ;
Patel, Anup D. ;
Cross, J. Helen ;
Villanueva, Vicente ;
Wirrell, Elaine C. ;
Privitera, Michael ;
Greenwood, Sam M. ;
Roberts, Claire ;
Checketts, Daniel ;
VanLandingham, Kevan E. ;
Zuberi, Sameer M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (20) :1888-1897
[6]   Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial [J].
Devinsky, Orrin ;
Marsh, Eric ;
Friedman, Daniel ;
Thiele, Elizabeth ;
Laux, Linda ;
Sullivan, Joseph ;
Miller, Ian ;
Flamini, Robert ;
Wilfong, Angus ;
Filloux, Francis ;
Wong, Matthew ;
Tilton, Nicole ;
Bruno, Patricia ;
Bluvstein, Judith ;
Hedlund, Julie ;
Kamens, Rebecca ;
Maclean, Jane ;
Nangia, Srishti ;
Singhal, Nilika Shah ;
Wilson, Carey A. ;
Patel, Anup ;
Cilio, Maria Roberta .
LANCET NEUROLOGY, 2016, 15 (03) :270-278
[7]   CLINICAL UPDATE Medicinal use of cannabis based products and cannabinoids [J].
Freeman, Tom P. ;
Hindocha, Chandni ;
Green, Sebastian F. ;
Bloomfield, Michael A. P. .
BMJ-BRITISH MEDICAL JOURNAL, 2019, 365
[8]   Pharmacology of cannabinoids in the treatment of epilepsy [J].
Gaston, Tyler E. ;
Friedman, Daniel .
EPILEPSY & BEHAVIOR, 2017, 70 :313-318
[9]   Drug development for refractory epilepsy: The past 25 years and beyond [J].
Golyala, Ambica ;
Kwan, Patrick .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2017, 44 :147-156
[10]   Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents - An observational, longitudinal study [J].
Hausman-Kedem, Moran ;
Menascu, Shay ;
Kramer, Uri .
BRAIN & DEVELOPMENT, 2018, 40 (07) :544-551